ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury. (Q36597266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Henri Leuvenink

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Willem G van Rijt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Gertrude J Nieuwenhuijs-Moeke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Petra J Ottens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Rutger J Ploeg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Harry van Goor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

9 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

Journal of Translational Medicine

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

21 February 2020

copyright license

start time

9 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1479-5876-11-9

0 references

cites work

Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Randomized trial of short-course high-dose erythropoietin in donation after cardiac death kidney transplant recipients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3567997

Nitrite and nitrate determinations in plasma: a critical evaluation

20 September 2018

1 reference

12 December 2020

Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans

1 reference

12 December 2020

Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure

1 reference

12 December 2020

Kidney transplantation from donors after cardiac death: a 25-year experience

1 reference

12 December 2020

β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase

1 reference

12 December 2020

High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation

1 reference

12 December 2020

Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway

1 reference

12 December 2020

Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation

1 reference

12 December 2020

Identifiers

DOI

10.1186/1479-5876-11-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23302512%20AND%20SRC:MED&resulttype=core&format=json